ThursdayAug 01, 2024 10:44 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Conference Call, Webcast to Discuss Q2 Results

HeartBeam(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has scheduled a conference call and webcast to discuss its second-quarter 2024 results. According to the announcement, the call is slated to begin at 4:30 p.m. ET on Aug. 14, 2024. HeartBeam executives, including Branislav Vajdic, CEO and founder; Robert Eno, president; and Ravi Malhotra, senior director and corporate controller, will host the call. During the call, the company leaders will discuss second-quarter results, provide regulatory updates, and review ongoing initiatives and anticipated 2024 milestones; the call will also include a question-and-answer period.…

Continue Reading

WednesdayJul 31, 2024 2:02 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Date for Release of Q2 2024 Financial Results

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, will release its financial results for the second quarter of 2024 on Aug. 8, 2024, before the market opens. The financial report will cover the three and six month periods ended June 30, 2024. In addition, the company has scheduled a conference call on that same day. The call will begin at 8 a.m. ET. During the call, CEO Dr. Alan Baratz and CFO John Markovich will discuss the results and business outlook. Those wishing to access the call can dial 1-800-717-1738 (domestic) or 1-646-307-1865…

Continue Reading

WednesdayJul 31, 2024 1:50 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) to Participate as an Anchor Organization at the 2024 Southeastern United States – Canadian Provinces Business Forum

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is participating as an Anchor Organization and panelist at the 2024 Southeastern United States - Canadian Provinces (“SEUS-CP”) Business Forum. The 2024 SEUS-CP is set to take place August 4-6 in Biloxi, Mississippi; Mississippi is home to Mullen’s commercial EV manufacturing. Mullen is a confirmed Anchor Organization at the event alongside other companies. According to the announcement, this year’s business forum focuses on Advanced Manufacturing (Aerospace and Electric Vehicle Technologies and Components) and the Blue Economy (Shipbuilding, UAVs, Smart Ports Energy, Innovative Materials, Innovative Technologies & Data Analytics, Fisheries &…

Continue Reading

TuesdayJul 30, 2024 2:23 pm

QualityStocksNewsBreaks – PayPal Holdings Inc. (NASDAQ: PYPL) Surpasses Quarterly Earnings Expectations

PayPal Holdings (NASDAQ: PYPL), a leading digital payments platform, recently reported its quarterly earnings, showcasing a performance that exceeded expectations. The company announced earnings of $1.19 per share, surpassing the Zacks Consensus Estimate of $0.96 per share. This marks an improvement from the $1.16 per share reported a year ago, representing an earnings surprise of nearly 24%. PayPal’s ability to consistently outperform consensus EPS estimates over the last four quarters highlights its robust financial health and operational efficiency. For the quarter ending in June 2024, PayPal posted revenues of $7.89 billion, exceeding the Zacks Consensus Estimate by 1.04%. This revenue figure represents…

Continue Reading

TuesdayJul 30, 2024 11:48 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Long-Term Study Results Confirm Positive Results of Developing Treatment for AD

InMed Pharmaceuticals (NASDAQ: INM), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, is reporting on positive results from a long-term study of INM-901. The in vivo preclinical Alzheimer's disease (“AD”) involved seven months of dosing and confirms findings from an earlier short-term pilot study. The company reported that results from the study confirm improvements in cognitive function, memory and locomotor activity and show statistical significance in certain behavioral assessments.According to the announcement, InMed is moving forward with additional molecular analyses to better define the mechanisms of action and…

Continue Reading

TuesdayJul 30, 2024 10:31 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered into an exclusive license agreement with Cortice Biosciences Inc. Through the agreement, CNS Pharmaceuticals has acquired a license as well as the intellectual property rights to a potentially blood-brain-barrier, permeable microtubule inhibitor called TPI 287. The inhibitor is being developed for the treatment of glioblastoma multiforme (“GBM”). In return for the license, CNS Pharmaceuticals will pay Cortice an up-front payment of 616,698 shares of its common stock, as well as the possibility…

Continue Reading

MondayJul 29, 2024 1:48 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Receives Order for Mullen Campus EVs from Leading Transportation and Logistics Company

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has received an order for four Mullen Campus electric vehicles from DB Schenker, one of the world’s leading transportation and logistics companies. According to the announcement, the vehicles will be used for mail and delivery on Intel’s technology campus in Chandler, Arizona. The order was received through one of Mullen’s commercial vehicle dealers, Randy Marion Automotive. The dealer has received payment for the vehicles, and the vehicles have been delivered to DB Schenker. According to the company, the Mullen Campus is a highly efficient electric van designed for low-speed, closed-campus use.…

Continue Reading

FridayJul 26, 2024 3:15 pm

QualityStocksNewsBreaks – Glidelogic Corp. (GDLG) Unveils ‘Groundbreaking’ Copyright Protection for AI-Generated Content

Glidelogic (OTC: GDLG), a diversified software development company specializing in artificial intelligence, fintech, and blockchain technology development and consulting, has announced a groundbreaking solution for copyright protection of artificial intelligence (“AI”)-generated content. According to the announcement, the offering combines Glidelogic's patented technology with Propaganda GEM's industry resources, creating a copyright management system designed for digital content creators and users. The technology utilizes a large model to encode copyrighted content with user information, generating customized NFTs and ensuring the uniqueness of each work while also providing a clear chain of copyright ownership and ensuring content is legal and compliant. Propaganda GEM…

Continue Reading

FridayJul 26, 2024 2:23 pm

QualityStocksNewsBreaks – Match Group Inc. (NASDAQ: MTCH) Sees Investment Surge from Starboard Value

Match Group (NASDAQ: MTCH), a leading company in the online dating industry, operates well-known platforms such as Tinder, Hinge, and OkCupid. The company has recently been in the spotlight due to a significant investment by the activist hedge fund Starboard Value, which has acquired approximately 6.6% of Match Group, making it the third-largest shareholder. Starboard Value’s involvement is not just a passive investment. In a detailed letter to Match Group’s leadership, Jeffrey Smith, Starboard Value’s Managing Member, outlined several recommendations aimed at boosting the company’s financial performance. Among these suggestions was the need for Match to improve its profit margins,…

Continue Reading

ThursdayJul 25, 2024 1:36 pm

QualityStocksNewsBreaks – FSD Pharma Inc.’s (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Revolutionary Rapid Detoxification Drink Spotlighted in 24/7 Market News Report

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, has been featured in a news report published by 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information. The report, which highlights functional beverage market developments, discusses FSD Pharma’s revolutionary rapid detoxification drink, unbuzzd(TM). The drink helps to rapidly restore mental alertness post-alcohol consumption. To read the full news report, visit https://ibn.fm/9qlBY To view the full press release, visit https://ibn.fm/FCJ7S About FSD Pharma Inc. FSD is a biopharmaceutical company dedicated to…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered